Skip to main content
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc. — Investor Relations & Filings

Ticker · IMDX ISIN · US68235C1071 LEI · 549300BIYAW8GO410287 US Human health and social work activities
Filings indexed 646 across all filing types
Latest filing 2024-05-15 Interim / Quarterly Rep…
Country US United States of America
Listing US IMDX

About Insight Molecular Diagnostics Inc.

https://imdxinc.com/

Insight Molecular Diagnostics Inc. (iMDx) is a precision diagnostics company that develops and commercializes molecular diagnostic tests. The company focuses on advancing precision medicine in transplantation and oncology. Its solutions are designed for researchers, clinicians, and healthcare systems to enable early detection, guide treatment, and accelerate discovery. Key products include blood-based tests for transplant monitoring that quantify donor-derived cell-free DNA (dd-cfDNA) to assess organ health following transplantation. In oncology, the company provides tools to support cancer immunotherapy guidance. iMDx aims to deliver accurate and scalable diagnostic tools that provide clear, actionable insights for clinical and research decision-making.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2024
Interim / Quarterly Report Q1 2024
2024-05-15 English
Regulatory Filings 2024
Regulatory Filings
2024-05-14 English
Regulatory Filings 2024
Regulatory Filings
2024-05-10 English
Proxy Solicitation & Information Statement 2024
Proxy Solicitation & Information Statement
2024-04-29 English
Regulatory Filings 2024
Regulatory Filings
2024-04-24 English
Annual Report 2023
Annual Report FY 2023
2024-04-15 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.